Management of patients with hidradenitis suppurativa during the COVID-19 pandemic

Dermatol Ther. 2020 Nov;33(6):e13875. doi: 10.1111/dth.13875. Epub 2020 Jul 7.

Authors

Trinidad Montero-Vilchez¹, Antonio Martinez-Lopez^{1

2}, Luis Salvador-Rodriguez¹, Alejandro Molina-Leyva^{1

2}, Salvador Arias-Santiago^{1

2}

Affiliations

¹ Department of Dermatology, Hospital Universitario Virgen de las Nieves, Granada, Spain.
² Instituto de Investigación Biosanitaria (ibs.Granada), Granada, Spain.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 / epidemiology*
COVID-19 / etiology
Hidradenitis Suppurativa / complications
Hidradenitis Suppurativa / drug therapy*
Humans
SARS-CoV-2*